Breaking News Instant updates and real-time market news.

ALXN

Alexion

$135.20

-3.82 (-2.75%)

05:25
10/24/17
10/24
05:25
10/24/17
05:25

Alexion announces FDA approval of Soliris

Alexion Pharmaceuticals announced that the FDA has approved Soliris as a treatment for adult patients with generalized myasthenia gravis, or gMG, who are anti-acetylcholine receptor, or AchR, antibody-positive. In the Phase 3 REGAIN study and its ongoing open-label extension study, Soliris demonstrated treatment benefits for patients with anti-AchR antibody-positive gMG who had previously failed immunosuppressive treatment and continued to suffer from significant unresolved disease symptoms, which can include difficulties seeing, walking, talking, swallowing and breathing. These patients are at an increased risk of disease exacerbations and crises that may require hospitalization and intensive care and may be life-threatening. These patients represent approximately 5%-10% of all patients with MG.

  • 24

    Oct

  • 26

    Oct

  • 06

    Nov

ALXN Alexion
$135.20

-3.82 (-2.75%)

10/23/17
PIPR
10/23/17
INITIATION
Target $170
PIPR
Overweight
Alexion assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Christopher Raymond assumed coverage of Alexion Pharmaceuticals with an Overweight rating and $170 price target. The rating is unchanged and the price target is raised from $168. The analyst believes the base business has been stabilized and expects "meaningful progress" into 2018 as management executes on its strategic refocusing.
10/13/17
LEHM
10/13/17
NO CHANGE
LEHM
Barclays cautious on Merck and Regeneron into Q3 results
In a research note previewing the Q3 earnings reports for U.S. Biopharmaceuticals, Barclays analyst Geoff Meacham says he's positive on positive on Amgen (AMGN) and Alexion Pharmaceuticals (ALXN), cautious on Merck (MRK), and bearish on Regeneron (REGN). The analyst made a host of price target changes, including raising Amgen's target to $190 from $180, AbbVie's (ABBV) target to $90 from $68 and Bristol-Myers' target to $65 from $58.
09/25/17
LEER
09/25/17
NO CHANGE
Target $182
LEER
Outperform
Alexion Soliris to continue dominance through 2020, says Leerink
Leerink analyst Geoffrey Porges notes that Alexion's Soliris was the first complement inhibitor to be approved by the FDA or EMA and has remained the only terminal complement inhibitor on the market. While some competitors have advanced to pivotal trials, and have established safety and efficacy, none have shown themselves to be superior to Soliris in efficacy, nor more convenient than ALXN1210, he adds. The analyst believes the development timelines for these new entrants suggest that Soliris will continue its dominance of the category through 2020, and even then will face its biggest challenge from Alexion's own next generation complement inhibitor, ALXN1210. Porges reiterates an Outperform rating and $182 price target on the shares.
09/14/17
RBCM
09/14/17
INITIATION
Target $161
RBCM
Outperform
Alexion initiated with an Outperform at RBC Capital
RBC Capital analyst Kennen MacKay initiated Alexion with an Outperform and a $161 price target saying shares are undervalued following management changes and restructuring. He said Soliris market dynamics suggest continued future growth despite PNH Patient competition.

TODAY'S FREE FLY STORIES

T

AT&T

$34.25

-0.08 (-0.23%)

, TWX

Time Warner

$89.74

0.18 (0.20%)

09:53
11/22/17
11/22
09:53
11/22/17
09:53
Conference/Events
FBN Securities strategist to hold an analyst/industry conference call »

FBN Securities…

T

AT&T

$34.25

-0.08 (-0.23%)

TWX

Time Warner

$89.74

0.18 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

CUB

Cubic

$62.00

1.25 (2.06%)

09:52
11/22/17
11/22
09:52
11/22/17
09:52
Technical Analysis
Technical View: Cubic up on mobile ticketing contract win for Rhein-Sieg area »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

SAN

Banco Santander

$6.49

0.09 (1.41%)

09:50
11/22/17
11/22
09:50
11/22/17
09:50
Options
Santander Mar 7 calls active at the opening bell Wednesday »

Santander Mar 7 calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$2.31

-0.0094 (-0.41%)

09:46
11/22/17
11/22
09:46
11/22/17
09:46
Hot Stocks
22nd Century to discontinue U.S. sales of RED SUN brand cigarettes »

22nd Century Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
11/22/17
11/22
09:45
11/22/17
09:45
General news
Consumer Sentiment Index to be reported at 10:00 »

Consumer Sentiment Index…

SAN

Banco Santander

, GME

GameStop

09:40
11/22/17
11/22
09:40
11/22/17
09:40
Options
Unusually active option classes on open November 22nd »

Unusual total active…

SAN

Banco Santander

GME

GameStop

HPE

HP Enterprise

HPQ

HP Inc.

CRM

Salesforce

SWKS

Skyworks

$110.25

0.46 (0.42%)

LRCX

Lam Research

$218.91

3.81 (1.77%)

SBUX

Starbucks

$57.26

0.45 (0.79%)

BIDU

Baidu

$244.30

5.76 (2.41%)

AMAT

Applied Materials

$58.80

1.18 (2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 25

    Jan

XLE

Energy Select Sector SPDR

09:40
11/22/17
11/22
09:40
11/22/17
09:40
Technical Analysis
Technical View: Energy Select Sector SPDR leads index on the upside »

The Energy Select Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

, HD

Home Depot

09:37
11/22/17
11/22
09:37
11/22/17
09:37
Recommendations
Lowe's, Home Depot analyst commentary  »

Lowe's price target…

LOW

Lowe's

HD

Home Depot

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

09:35
11/22/17
11/22
09:35
11/22/17
09:35
General news
U. Michigan sentiment preview: »

U. Michigan sentiment…

CHFS

CHF Solutions

$7.88

-0.24 (-2.96%)

09:31
11/22/17
11/22
09:31
11/22/17
09:31
Syndicate
CHF Solutions announces $18M public offering »

CHF Solutions announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTL

Mechel

09:31
11/22/17
11/22
09:31
11/22/17
09:31
Hot Stocks
Mechel announces reversal of Court decision »

Mechel reports a court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
11/22/17
11/22
09:30
11/22/17
09:30
General news
The U.S. durables report undershot estimates »

The U.S. durables report…

09:30
11/22/17
11/22
09:30
11/22/17
09:30
General news
Breaking General news story  »

Week of 11/19 Bloomberg…

SNPS

Synopsys

$89.38

0.48 (0.54%)

09:29
11/22/17
11/22
09:29
11/22/17
09:29
Recommendations
Synopsys analyst commentary  »

Synopsys price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQUA

Evoqua Water

09:26
11/22/17
11/22
09:26
11/22/17
09:26
Hot Stocks
Evoqua Water names Dan Brailer head of investor relations »

Evoqua Water announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROK

Rockwell Automation

, EMR

Emerson

09:26
11/22/17
11/22
09:26
11/22/17
09:26
Recommendations
Rockwell Automation, Emerson analyst commentary  »

Latest Rockwell rebuff…

ROK

Rockwell Automation

EMR

Emerson

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
11/22/17
11/22
09:25
11/22/17
09:25
General news
Fed funds futures are slightly firmer toward the back end of the curve »

Fed funds futures are…

PBYI

Puma Biotechnology

$104.90

0.85 (0.82%)

09:24
11/22/17
11/22
09:24
11/22/17
09:24
Hot Stocks
Puma Biotechnology, Specialised Therapeutics Asia enter licensing agreement »

Puma Biotechnology and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

09:22
11/22/17
11/22
09:22
11/22/17
09:22
Hot Stocks
Whitman 'definitively' says not running for President or any other office »

Meg Whitman, speaking in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 11

    Dec

PG

Procter & Gamble

09:22
11/22/17
11/22
09:22
11/22/17
09:22
Hot Stocks
Trian comments on Procter & Gamble's contest to voting tabulation »

Trian Fund Management,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

, SFL

Ship Finance

09:22
11/22/17
11/22
09:22
11/22/17
09:22
Hot Stocks
On The Fly: Pre-market Movers »

UP AFTER EARNINGS: Deere…

DE

Deere

SFL

Ship Finance

EMR

Emerson

ROK

Rockwell Automation

FRO

Frontline

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 22

    Nov

  • 28

    Nov

SIG

Signet Jewelers

09:22
11/22/17
11/22
09:22
11/22/17
09:22
Recommendations
Signet Jewelers analyst commentary  »

Signet Jewelers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

WWE

WWE

09:20
11/22/17
11/22
09:20
11/22/17
09:20
Conference/Events
WWE management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

HPE

HP Enterprise

09:19
11/22/17
11/22
09:19
11/22/17
09:19
Hot Stocks
Whitman says 'probably have more confidence' now in previously issued guidance »

HP Enterprise CEO Meg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 11

    Dec

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
11/22/17
11/22
09:18
11/22/17
09:18
Options
Overnight activity included 57 trades in SPX and 19 trades in VIX »

57 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.